GCITX
Price
$19.28
Change
+$0.08 (+0.42%)
Updated
Jun 2 closing price
Net Assets
6.67B
MDIHX
Price
$29.88
Change
+$0.19 (+0.64%)
Updated
Jun 2 closing price
Net Assets
44.56B
Interact to see
Advertisement

GCITX vs MDIHX

Header iconGCITX vs MDIHX Comparison
Open Charts GCITX vs MDIHXBanner chart's image
GCITX vs MDIHX Comparison Chart in %
View a ticker or compare two or three
VS
GCITX vs. MDIHX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCITX is a Buy and MDIHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 44.6B vs. GCITX (6.67B). MDIHX pays higher dividends than GCITX: MDIHX (1.85) vs GCITX (1.48). GCITX was incepted earlier than MDIHX: GCITX (19 years) vs MDIHX (21 years). MDIHX (1.10) is less costly to investors than GCITX (0.94). GCITX is a more actively managed with annual turnover of: 156.00 vs. MDIHX (2.00). GCITX (0) and MDIHX (0) have matching initial minimum investment requirements. GCITX annual gain was more profitable for investors over the last year : 21.32 vs. MDIHX (17.73). GCITX return over 5 years is better than : 50.55 vs. MDIHX (27.94).
GCITXMDIHXGCITX / MDIHX
Total Expense Ratio0.911.0884%
Annual Report Gross Expense Ratio0.941.1085%
Fund Existence19 years21 years-
Gain YTD12.1509.436129%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.67B44.6B15%
Annual Yield % from dividends1.481.8580%
Returns for 1 year21.3217.73120%
Returns for 3 years67.5946.99144%
Returns for 5 years50.5527.94181%
Returns for 10 years134.75123.06109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPPL3.910.32
+8.91%
Simpple Ltd
TXN308.1214.92
+5.09%
Texas Instruments
WNC7.790.15
+1.96%
Wabash National Corp
KNSL295.40-8.13
-2.68%
Kinsale Capital Group
VIR8.74-0.29
-3.21%
Vir Biotechnology